Literature DB >> 10638700

Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content.

J C Barton1, L F Bertoli, B E Rothenberg.   

Abstract

We studied peripheral blood erythrocyte parameters and HFE genotypes in 94 hemochromatosis probands and 132 white, normal control subjects. Mean red blood cell counts in probands and control subjects were not significantly different. However, mean values of hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC) were significantly higher in C282Y/C282Y probands (n = 60) than in wild-type control subjects (n = 65). Probands with other HFE genotypes also had increased mean erythrocyte parameters (other than red blood cell count). Peripheral blood smears prepared before therapeutic phlebotomy revealed that erythrocytes in many probands had increased diameters and were well filled with hemoglobin. Erythrocyte parameters were similar in C282Y/C282Y probands with and without hepatomegaly, elevated serum concentrations of hepatic enzymes, hepatic cirrhosis, diabetes mellitus, arthropathy, or hypogonadism. Among C282Y/C282Y probands, significantly greater values of MCV (but not other erythrocyte parameters) occurred among those who had transferrin saturation values of 75% or greater or iron overload at diagnosis. After iron depletion, the mean MCV, MCH, and MCHC values of C282Y/C282Y probands decreased but remained significantly greater than values in wild-type control subjects. Mean values of prephlebotomy MCH and MCHC concentrations were lower in HLA-A3-positive than in HLA-A3-negative C282Y/C282Y probands. We conclude that increased values of mean hemoglobin, hematocrit, MCV, MCH, and MCHC in hemochromatosis probands are caused primarily by increased iron uptake and hemoglobin synthesis by immature erythroid cells. Mechanisms of iron uptake by erythrocytes that could explain these results are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638700     DOI: 10.1016/s0022-2143(00)70026-6

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  19 in total

1.  Serum ferritin and erythrocyte indices in iron overload.

Authors:  Gemino Fiorelli
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

2.  Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts.

Authors:  De-Liang Zhang; Thomas Senecal; Manik C Ghosh; Hayden Ollivierre-Wilson; Tiffany Tu; Tracey A Rouault
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

3.  Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis.

Authors:  Pedro Ramos; Ella Guy; Nan Chen; Catia C Proenca; Sara Gardenghi; Carla Casu; Antonia Follenzi; Nico Van Rooijen; Robert W Grady; Maria de Sousa; Stefano Rivella
Journal:  Blood       Date:  2010-11-08       Impact factor: 22.113

Review 4.  Iron and erythropoiesis: a dual relationship.

Authors:  Clara Camaschella; Alessia Pagani
Journal:  Int J Hematol       Date:  2010-12-18       Impact factor: 2.490

5.  Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank.

Authors:  Eleanor L Watts; Aurora Perez-Cornago; Jaimal Kothari; Naomi E Allen; Ruth C Travis; Timothy J Key
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-26       Impact factor: 4.254

6.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

8.  HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  James S Pankow; Eric Boerwinkle; Paul C Adams; Eliseo Guallar; Catherine Leiendecker-Foster; Jason Rogowski; John H Eckfeldt
Journal:  Transl Res       Date:  2008-06-13       Impact factor: 7.012

Review 9.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

10.  Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis.

Authors:  Aleša Kristan; Tadej Pajič; Aleš Maver; Tadeja Režen; Tanja Kunej; Rok Količ; Andrej Vuga; Martina Fink; Špela Žula; Helena Podgornik; Saša Anžej Doma; Irena Preložnik Zupan; Damjana Rozman; Nataša Debeljak
Journal:  Front Genet       Date:  2021-07-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.